Skip to main content
. Author manuscript; available in PMC: 2013 Jan 23.
Published in final edited form as: Lab Invest. 2009 Dec 14;90(2):234–244. doi: 10.1038/labinvest.2009.127

Fig. 5.

Fig. 5

ALDH1A1 expression existed in PCa tumors with heterogeneous phenotypes and was associated with a poor prognosis for the patients. A. Immunohistochemical study of adjacent sections of a PCa tumor for the expression of ALDH1A1 and AR showed that ALDH1A1+ cells (arrows in left panel) exist in portion of secretory type cancer epithelial cells that had strong AR immunopositivity (arrowheads in right panel). B. ALDH1A1+ cells (arrows in left panel) were present in part of neuroendocrine tumor cells that had positive chromogranin A (arrowheads in right panel). C. Probability of overall survival (left panel) and cancer-specific survival (right panel) by levels of ALDH1A1 expression in the 99 PCa patients.